The ALS AssociationOnaylanmış hesap

@alsassociation

The ALS Association National Office / Fighting Lou Gehrig's Disease

Washington, D.C.
Şubat 2009 tarihinde katıldı

Tweetler

@alsassociation adlı kişiyi engelledin

Bu Tweetleri görüntülemek istediğinden emin misin? Tweetleri görüntülemek @alsassociation adlı kişinin engelini kaldırmaz.

  1. 8 saat önce

    What a great meeting – we came away with new colleagues and ideas to help ppl living w ! Thank you to our wonderful hosts , & . Looking forward to Glasgow next year!

  2. 9 saat önce

    Congratulations to Bernard Muller from Project MinE - recipient of the Patient Impact Award at ! So inspiring and well deserved!

  3. 9 saat önce

    In the last year, more than 48,000 people viewed, downloaded, or ordered our new educational materials, including the Living with ALS and Families and ALS resource guides and medical information packets.

  4. 9 saat önce

    Whether it’s , gene therapy, or RNA, we’ve made major progress in innovative research in 2017. Find out more about the progress we made this year:

  5. 12 saat önce

    A former Milton Safenowitz postdoctoral fellow Marka van Blitterswijk is looking at people w C9ORF72 mutation to identify new disease pathways which translate into new therapeutic targets. Great work!

  6. 12 saat önce

    Advocates built support for the ALS Disability Insurance Access Act in Congress this year, a key priority to improve access to needed services for people living with .

  7. 12 saat önce

    Great to hear the fast progress out of and its new partnership with Project MinE . Collaborations are key to finding a cure for ! Learn more:

  8. 13 saat önce

    We wrapped up the ALS IMPACT Survey in 2017! With the help of the almost 1,000 responses from our community, we’ll be better able to develop strategies to empower both caregivers and people living with ALS!

  9. 13 saat önce

    The ALS Association and our advocates joined with other leading organizations to protect the rights of people living with who are on Medicaid, ensuring access to care.

  10. 9 Ara

    Throughout 2017, we collaborated with 130+ clinical partners, incorporating American Academy of Neurology best practices.

  11. 9 Ara

    IMPACT ALS survey results shows that burden of is high – another step closer to establishing the burdens of daily life & identifying unmet medical needs of our community. We are excited to continue these critical studies! More results coming soon.

  12. 9 Ara

    Part of ALS PREFER – IMPACT ALS survey - was sent to people w & caregivers to gather data about disease burden, functional outcomes and treatment views. Thrilled to see a great response – 1,534 participants. Thank you to all that took part!

  13. 9 Ara

    It is important for ppl w to give input & integrate into drug development process. Together w & collaborators, we are developing ALS PREFER – a research driven platform building robust ALS patient preference studies. Thank u Lucie for presenting today!

  14. 9 Ara

    Dr. Bjorn Oskarsson FL, Director of one of our Certified Clinics, is presenting an analysis of studies treating muscle cramps for those living with . So helpful to be as informed as possible.

  15. 9 Ara

    After being newly diagnosed w , many people wonder if they can still exercise. A brand new study by funded Dr. Maragakis is showing that you still can exercise safely and tolerably! . Check out our blog for more:

  16. 9 Ara

    In 2004 we invested $1.5 million in therapy research. Fast forward to 2017, and we’ve already seen one approved drug & one more treatment drugs in clinical trials.

  17. 9 Ara

    Close collaborator, Dr. Kevin Horton & National Registry presents findings about how close ppl living with ALS are to clinics, 1 key to ensuring that all members of the ALS community have access to the care & support they need. Thank u for your hard work!

  18. 9 Ara

    Smoking cigarettes is a well-known cause of many health problems. Dr. Peters shows new findings presented at suggesting smoking increases the risk of , too.

  19. 9 Ara

    On stage now at Sheila Essey-award winner Adriano Chio presents studies to explore number of events that are necessary to cause neurodegeneration & how genetic mutations impact this number.

  20. 9 Ara

    Dr. Michael Benatar , one of our funded researchers, discusses insight into the longitudinal biomarker study of blood and CSF - called NfL- shows possible first biochemical biomarker of pre-symptomatic disease. Very exciting!

Yükleme biraz zaman alacak gibi görünüyor.

Twitter aşırı kapasiteyle çalışıyor ya da anlık sorunlar yaşıyor olabilir. Yeniden dene ya da daha fazla bilgi almak için Twitter Durumu sayfasını ziyaret et.

    Şunları da beğenebilirsin

    ·